PERCORTEN-V. INJECTABLE DIN 02139227
Status: Marketed
Holder: ELANCO CANADA LIMITED
Health Canada record
| Active ingredient(s) | DESOXYCORTONE PIVALATE 25 MG |
|---|
| Dosage form | Suspension |
|---|
| Route | Intramuscular |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 31-Dec-1996 |
|---|
| Current status date | 16-Jan-2018 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2022-08-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DESOXYCORTONE PIVALATE
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02453657 | ZYCORTAL SUSPENSION | DECHRA LTD | Suspension | DESOXYCORTONE PIVALATE 25 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 17440 | 2015-11-05 | New Drug Submission (NDS) | MERGER - BUYOUT |
| 6802 | 1997-08-13 | New Drug Submission (NDS) | |
| 7154 | 1995-01-27 | New Drug Submission (NDS) | |
Request a quote for PERCORTEN-V. INJECTABLE
How to read a Canadian DIN record